[HTML][HTML] COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment–A narrative review

CA Pfortmueller, T Spinetti, RD Urman… - Best Practice & …, 2021 - Elsevier
Abstract (163 words) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces coronavirus-19 disease (COVID-19) and is a major health concern. Following two …

Effect of coronary artery disease on COVID-19—prognosis and risk assessment: a systematic review and meta-analysis

L Szarpak, M Mierzejewska, J Jurek, A Kochanowska… - Biology, 2022 - mdpi.com
Simple Summary As of October 2021, over 245 million people have been infected and
nearly 5 million have died due to COVID-19. Atherosclerosis is a lipid-driven chronic …

The potential impact of COVID-19 virus on the heart and the circulatory system

MS Alqahtani, M Abbas, A Alsabaani… - Infection and Drug …, 2022 - Taylor & Francis
Heart attacks, arrhythmias, and cardiomyopathy are all linked to the 2019 coronavirus
disease (COVID-19), which has been identified as a risk factor for cardiovascular disease …

Long-term outcomes in acute respiratory distress syndrome: epidemiology, mechanisms, and patient evaluation

JA Palakshappa, JTW Krall, LT Belfield… - Critical Care …, 2021 - criticalcare.theclinics.com
Acute respiratory distress syndrome (ARDS) is a clinical syndrome of inflammatory lung
injury characterized by the acute onset of hypoxemia, noncardiogenic pulmonary edema …

Multimodality imaging for cardiac evaluation in patients with COVID-19

E Goerlich, AS Minhas, M Mukherjee… - Current Cardiology …, 2021 - Springer
Purpose of Review A growing number of cardiovascular manifestations resulting from the
novel SARS-CoV-2 coronavirus (COVID-19) have been described since the beginning of …

Myocarditis and autoimmunity

A Matsumori - Expert Review of Cardiovascular Therapy, 2023 - Taylor & Francis
Introduction Autoimmune myocarditis may develop due to heterogeneous causes.
Myocarditis is often caused by viral infections, but it can also be caused by systemic …

[图书][B] Role of Essential Oils in the Management of COVID-19

A Al-Harrasi, S Bhatia, T Behl, D Kaushik, MK Anwer… - 2021 - api.taylorfrancis.com
Coronavirus disease 2019 (COVID-19) has emerged as a global health threat.
Unfortunately, there are very limited approved therapeutics available with established …

Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients

C Loutradis, AG Pitoulias, E Pagkopoulou… - … Urology and Nephrology, 2022 - Springer
Abstract The coronavirus disease 2019 (COVID-19) is associated with increased mortality in
patients with chronic kidney disease (CKD), dialysis patients and kidney transplant …

2022 AHA/ACC key data elements and definitions for cardiovascular and noncardiovascular complications of COVID-19: a report of the American College of …

B Bozkurt, SR Das, D Addison, A Gupta… - … Quality and Outcomes, 2022 - Am Heart Assoc
Biykem Bozkurt, MD, PhD, FACC, FAHA, Chair; Sandeep R. Das, MD, MPH, FACC, FAHA,
Vice Chair; Daniel Addison, MD; Aakriti Gupta, MD, MS; Hani Jneid, MD, FACC, FAHA*; …

Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants

B Chatterjee, SS Thakur - Expert Review of Vaccines, 2022 - Taylor & Francis
ABSTRACT Introduction Appearances of SARS-CoV-2 variants have created havoc and
additional challenges for the ongoing vaccination drive against pandemic COVID-19 …